Adjunctive Hydrocortisone Improves Hemodynamics in Critically Ill Patients with Septic Shock: An Observational Study Using Transpulmonary Thermodilution

被引:1
|
作者
Jochheim, Leonie [1 ]
Jochheim, David [2 ]
Habenicht, Livia [3 ]
Herner, Alexander [3 ]
Ulrich, Joerg [3 ]
Wiessner, Johannes [3 ]
Heilmaier, Markus [3 ]
Rasch, Sebastian [3 ]
Schmid, R. M. [3 ]
Lahmer, T. [3 ]
Mayr, Ulrich [3 ]
机构
[1] Uniklinikum Essen, Klin Gastroenterol & Hepatol, Essen, Germany
[2] Med Versorgungszentrum MVZ Jochheim Med, Hattingen, Germany
[3] Tech Univ Munich, Med Klin & Poliklin 2, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany
关键词
septic shock; hydrocortisone; transpulmonary thermodilution; intensive care unit; vasopressor dependency index; cardiac power index; EXTRAVASCULAR LUNG WATER; INTERNATIONAL CONSENSUS DEFINITIONS; SEVERE SEPSIS; CARDIAC POWER; MORTALITY; FLUDROCORTISONE; GUIDELINES; MANAGEMENT; CARE;
D O I
10.1177/08850666231160664
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Septic shock is associated with high mortality and hemodynamic impairment. The use of corticoids is a common therapeutic tool in critically ill patients. However, data on the mechanisms and prognostic ability of hemodynamic improvement by adjunctive steroids are rare. This study primarily aimed to evaluate short-term effects of hydrocortisone therapy on catecholamine requirement and hemodynamics derived from transpulmonary thermodilution (TPTD) in 30 critically ill patients with septic shock and a 28 days mortality rate of 50%. Methods: Hydrocortisone was administered with an intravenous bolus of 200 mg, followed by a continuous infusion of 200 mg per 24 h. Hemodynamic assessment was performed immediately before as well as 2, 8, 16, and 24 h after the initiation of corticoids. For primary endpoint analysis, we evaluated the impact of hydrocortisone on vasopressor dependency index (VDI) and cardiac power index (CPI). Results: Adjunctive hydrocortisone induced significant decreases of VDI from 0.41 (0.29-0.49) mmHg(-1) at baseline to 0.35 (0.25-0.46) after 2 h (P < .001), 0.24 (0.12-0.35) after 8 h (P < .001), 0.18 (0.09-0.24) after 16 h (P < .001) and 0.11 (0.06-0.20) mmHg(-1) after 24 h (P < .001). In parallel, we found an improvement in CPI from 0.63 (0.50-0.83) W/m(2) at baseline to 0.68 (0.54-0.85) after 2 h (P = .208), 0.71 (0.60-0.90) after 8 h (P = .033), 0.82 (0.6-0.98) after 16 h (P = .004) and 0.90 (0.67-1.07) W/m(2) after 24 h (P < .001). Our analyses revealed a significant reduction in noradrenaline requirement in parallel with a moderate increase in mean arterial pressure, systemic vascular resistance index, and cardiac index. As a secondary endpoint, our results showed a significant decrease in lung water parameters. Moreover, changes in CPI (Delta CPI) and VDI (Delta VDI) after 24 h of hydrocortisone therapy revealed accurate prognostic ability to predict 28 days mortality (AUC = 0.802 vs 0.769). Conclusion: Adjunctive hydrocortisone leads to a rapid decrease in catecholamine requirement and a substantial circulatory improvement in critically ill patients with septic shock.
引用
收藏
页码:717 / 726
页数:10
相关论文
共 50 条
  • [41] Prospective Analysis of Critically Ill Patients with Gastrointestinal Bleeding: An Observational Study
    Yildirim, Mihriban
    Temel, Sahin
    Aslan, Merve
    Caliskan, Mustafa
    Karaoglu, Elif Nur
    Gundogan, Kursat
    Sungur, Murat
    JOURNAL OF CLINICAL PRACTICE AND RESEARCH, 2025, 47 (01): : 43 - 52
  • [42] Effects of adjunctive milrinone versus placebo on hemodynamics in patients with septic shock: a randomized controlled trial
    Tongyoo, Surat
    Chobngam, Suratee
    Yolsiriwat, Nutnicha
    Jiranakorn, Chutima
    ANNALS OF MEDICINE, 2025, 57 (01)
  • [43] Impact of CytoSorb and CKRT on hemodynamics in pediatric patients with septic shock: the PedCyto study
    Bottari, Gabriella
    Guzzo, Isabella
    Cappoli, Andrea
    Labbadia, Raffaella
    Perdichizzi, Salvatore
    Serpe, Carmela
    Creteur, Jacques
    Cecchetti, Corrado
    Taccone, Fabio Silvio
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [44] Fluid overload and mortality in critically ill patients with severe heart failure and cardiogenic shock-An observational cohort study
    Waskowski, Jan
    Michel, Matthias C. C.
    Steffen, Richard
    Messmer, Anna S. S.
    Pfortmueller, Carmen A. A.
    FRONTIERS IN MEDICINE, 2022, 9
  • [45] Circulating myeloperoxidase is elevated in septic shock and is associated with systemic organ failure and mortality in critically ill patients
    Carr, Anitra C.
    Spencer, Emma
    Hoskin, Teagan S.
    Rosengrave, Patrice
    Kettle, Anthony J.
    Shaw, Geoffrey
    FREE RADICAL BIOLOGY AND MEDICINE, 2020, 152 : 462 - 468
  • [46] Drug utilization pattern and cost for the treatment of severe sepsis and septic shock in critically ill cancer patients
    Nazer, Lama
    Al-Shaer, Mohammad
    Hawari, Feras
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1245 - 1250
  • [47] Hemoperfusion with Cytosorb in pediatric patients with septic shock: A retrospective observational study
    Bottari, Gabriella
    Guzzo, Isabella
    Marano, Marco
    Stoppa, Francesca
    Rava, Lucilla
    Di Nardo, Matted
    Cecchetti, Corrado
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2020, 43 (09) : 587 - 593
  • [48] Clinical significance of thrombocytopenia in patients with septic shock: An observational retrospective study
    Peju, Edwige
    Fouque, Gaelle
    Charpentier, Julien
    Vigneron, Clara
    Jozwiak, Mathieu
    Cariou, Alain
    Mira, Jean-Paul
    Jamme, Matthieu
    Pene, Frederic
    JOURNAL OF CRITICAL CARE, 2023, 76
  • [49] Effect of methylprednisolone vs hydrocortisone on 30-day mortality in critically ill adults with septic shock: an analysis of the MIMIC-IV database
    Xu, Jun
    Cai, Hongliu
    Zheng, Xia
    BMC INFECTIOUS DISEASES, 2025, 25 (01)
  • [50] Evaluation of Amiodarone Use for New-Onset Atrial Fibrillation in Critically Ill Patients With Septic Shock
    Betthauser, Kevin D.
    Gibson, Gabrielle A.
    Piche, Shannon L.
    Pope, Hannah E.
    HOSPITAL PHARMACY, 2021, 56 (02) : 116 - 123